A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope and concerns about transparency and ethics.

Imagine a world without disease. Sounds utopian? AI just made it a multibillion-dollar bet to discover drugs – and forget Big Pharma, Big Tech is all in on it, finds Satyen K. Bordoloi. In February ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting everything on AI to beat the odds.

It’s a sentiment felt widely across the medical field as AI starts to touch nearly every corner of medical research, physician training and processes, and patient care. The rollout of AI across health ...

As usual, the one-two punch of ASCO and BIO set us a bit behind, but never fear – your June hires round-up is here at least ...

China's systemic integration, America's AGI ambition, Russia's security focus, Taiwan's hardware leadership, South Korea's ...

Each year, the World Economic Forum (WEF) releases its Technology Pioneers list – a curated collection of companies that are ...

The much-maligned 1995 cyberpunk film envisioned a world of tech addiction, brain implants, and AI companions—ideas that feel ...

Reduce development timelines and costs, while improving access to life-saving treatments VANCOUVER, BC / ACCESS Newswire / July 30, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfur ...

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...